Johnson & Johnson’s TB drug SIRTURO receives full approval from FDA and EC

In a significant development for the treatment of drug-resistant tuberculosis (TB), Johnson & Johnson has announced that SIRTURO (bedaquiline) has received full approval from the ... Read More